* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Open
Epidemiology of metabolic syndrome wikipedia , lookup
Health equity wikipedia , lookup
Race and health wikipedia , lookup
Medical ethics wikipedia , lookup
Adherence (medicine) wikipedia , lookup
Forensic epidemiology wikipedia , lookup
Patient safety wikipedia , lookup
Electronic prescribing wikipedia , lookup
Case-Control Investigation of a DrugResistant Acinetobacter baumannii Outbreak at a Regional Medical Center in Eastern Kentucky, 2010 Alexander J. Freiman, MPH, CPH CDC/CSTE Applied Epidemiology Fellow Kentucky Department for Public Health June 15, 2011 1 Background  A. baumannii Aerobic, gram negative bacteria  Persist in environment  Person-person or direct contact  Drug resistance   Outbreaks of multi drug-resistant (MDR) A. baumannii in healthcare setting a growing concern Healthcare-associated infection  Especially in intensive care units (ICUs)  2 Background  Kentucky Department for Public Health (KDPH) notified of Acinetobacter outbreak in September, 2010   66 cases initially reported Assistance requested from KDPH New Infection Preventionist  Reported gaps in infection control process  Hand hygiene  Lacked comprehensive environmental cleaning protocols  3 Background   Response team assembled from KDPH and began on-site evaluation CDC collaboration Medical epidemiologist  Laboratory experts  4 Objectives  Two main objectives Identify risk factors associated with recovery of A. baumannii in hospitalized ICU patients  Investigate potential environmental sources of A. baumannii in healthcare facility  5 Methods  Study Design   Case-control Case definition: Laboratory-confirmed cultures of MDR A. baumannii ≥72 hours after hospital admission  ICU admission  January-September 2010  6 Methods  Control definition ICU admission  December 2009-October 2010  No history of A. baumannii infection in chart   Controls were matched to cases 1:1 ICU admission date  ICU length of stay  7 Methods  Abstracted information from medical records Demographics  Admission/discharge  Medical history  Laboratory results  Consultations  Procedures  Medications  8 Methods  Statistical Analysis Frequencies  T-test, Chi square test, Fisher’s exact test  Odds ratios between potential risk factors and MDR A. baumannii recovery using logistic regression  Univariate  Multivariate   Conducted using SPSS software 9 Methods   Collected environmental samples using wide sponge culturettes Site selection High touch surfaces in areas with infected patients  Identified in previous studies  CDC recommendations  10 Methods  One sample taken at each of five sites ICU glucometer  ICU medication dispensing unit  ICU nursing station digital camera  Portable x-ray machine  Countertops in radiology unit  11 Methods   Five environmental and three patient samples sent to state and CDC labs for pulsed field gel electrophoresis (PFGE) typing Similarity between strains from environmental and patient samples determined using computer software 12 Case Selection 13 Case Selection 14 Case Selection 15 Case Selection 16 Results Number of cases Epidemic curve for MDR A. baumannii cases in an eastern Kentucky regional medical center, 2010 (N=30) 9 8 7 6 5 4 3 2 1 0 Jan Feb Mar Apr May Jun Jul Aug Sep Month 17 Results Selected Characteristics of Cases and Controls Characteristic Race/Ethnicity Caucasian Non-Hispanic Age (in years) Mean Median Range Sex Female Comorbidity Diabetes Case n (%) Control n (%) P value 29 (97) 29 (97) 29 (97) 29 (97) 1.00 1.00 68 70 40-87 67 69 38-105 0.72 12 (40) 17 (57) 0.30 18 (60) 10 (33) 0.04 18 Results Source of MDR A. baumannii culture from cases (N=30) Source Respiratory Blood Wound Urine n (%) 19 (63) 5 (17) 4 (13) 2 (7) 19 Results Environmental culture results Site Portable x-ray machine ICU nursing station digital camera ICU medication dispensing unit ICU glucometer Countertops in radiology unit Result Positive Positive Negative Negative Negative 20 Results * * Patient 4 from another healthcare facility 21 Results * * Patient 4 from another healthcare facility 22 Results * * Patient 4 from another healthcare facility 23 Results * * Patient 4 from another healthcare facility 24 Results Crude Associations for Risk Factors and Positive MDR A. baumannii Culture Risk Factors Received subcutaneous or intravenous insulin Fingersticks performed Total number of chest x-ray procedures Diabetic Central line performed Decubitis ulcer present Consulted with occupational therapist Did patient have cardiovascular issues Obese *p value ≤ 0.05 OR 4.97 5.02 1.10 3.00 3.14 2.62 3.08 3.27 2.41 P value 0.014* 0.025* 0.032* 0.041* 0.043* 0.072 0.094 0.107 0.111 95% Confidence Interval (1.39, 17.82) (1.23, 20.49) (1.01, 1.21) (1.05, 8.60) (1.03, 9.55) (0.92, 7.46) (0.82, 11.50) (0.77, 13.83) (0.82, 7.10) 25 Results Crude Associations for Risk Factors and Positive MDR A. baumannii Culture Risk Factors Received subcutaneous or intravenous insulin Fingersticks performed Total number of chest x-ray procedures Diabetic Central line performed Decubitis ulcer present Consulted with occupational therapist Did patient have cardiovascular issues Obese *p value ≤ 0.05 OR 4.97 5.02 1.10 3.00 3.14 2.62 3.08 3.27 2.41 P value 0.014* 0.025* 0.032* 0.041* 0.043* 0.072 0.094 0.107 0.111 95% Confidence Interval (1.39, 17.82) (1.23, 20.49) (1.01, 1.21) (1.05, 8.60) (1.03, 9.55) (0.92, 7.46) (0.82, 11.50) (0.77, 13.83) (0.82, 7.10) 26 Results Crude Associations for Risk Factors and Positive MDR A. baumannii Culture Risk Factors Received subcutaneous or intravenous insulin Fingersticks performed Total number of chest x-ray procedures Diabetic Central line performed Decubitis ulcer present Consulted with occupational therapist Did patient have cardiovascular issues Obese *p value ≤ 0.05 OR 4.97 5.02 1.10 3.00 3.14 2.62 3.08 3.27 2.41 P value 0.014* 0.025* 0.032* 0.041* 0.043* 0.072 0.094 0.107 0.111 95% Confidence Interval (1.39, 17.82) (1.23, 20.49) (1.01, 1.21) (1.05, 8.60) (1.03, 9.55) (0.92, 7.46) (0.82, 11.50) (0.77, 13.83) (0.82, 7.10) 27 Results Adjusted Associations for Risk Factors and MDR A. baumannii Culture for Sampled Equipment Risk Factors OR P value 95% Confidence Interval Fingersticks performed* 4.34 0.048 (1.01, 18.62) Total number of chest x-ray procedures† 1.10 0.065 (0.99, 1.22) Decubitis ulcer photographed* 2.71 0.083 (0.88, 8.37) *Model adjusted for age, type of admission, and mechanical ventilation †Model adjusted for age, type of admission, and fingersticks 28 Results Adjusted Associations for Risk Factors and MDR A. baumannii Culture for Sampled Equipment Risk Factors OR P value 95% Confidence Interval Fingersticks performed* 4.34 0.048 (1.01, 18.62) Total number of chest x-ray procedures† 1.10 0.065 (0.99, 1.22) Decubitis ulcer photographed* 2.71 0.083 (0.88, 8.37) *Model adjusted for age, type of admission, and mechanical ventilation †Model adjusted for age, type of admission, and fingersticks 29 Discussion  Lab cultures identified two possible sources for MDR A. baumannii transmission to patients in the facility    Portable chest x-ray machine Digital camera used for wound photography PFGE pattern similarity between environmental and patient samples matched between 92-100% 30 Discussion   Epidemiologic analysis suggests receiving fingersticks is a risk factor for becoming a case Breakdowns in disease prevention activities Hand hygiene  Cleaning shared equipment   Lack of clear equipment-cleaning responsibility might have contributed to ongoing transmission 31 Discussion  Limitations  Generalizability   Reliability   Small sample Cases: Controls only 1:1 Validity Lack of true electronic medical records  Incomplete line listing from healthcare facility  32 Discussion   Have procedures in place to clean all shared equipment Recognition of an outbreak and immediate implementation of effective controls is CRITICAL to preventing MDR A. baumannii transmission in the healthcare setting 33 Acknowledgments Kentucky Department for Public Health Margaret A. Riggs, PhD, MPH, MA Fontaine Sands, DrPH, MSN, CIC David R. Reese, MA, MPH, FRSPH Kraig E. Humbaugh, MD, MPH Doug Thoroughman, PhD, MS Robert L. Brawley, MD, MPH, FSHEA Centers for Disease Control and Prevention, Division of Healthcare Quality and Promotion Alexander J. Kallen, MD, MPH Judith Noble-Wang, PhD Heather A. O’Connell, PhD 34 Acknowledgments  This study was supported in part by an appointment to the Applied Epidemiology Fellowship Program administered by the Council of State and Territorial Epidemiologists (CSTE) and funded by the Centers for Disease Control and Prevention (CDC) Cooperative Agreement Number 5U38HM000414. 35 Contact Information Alex Freiman CDC/CSTE Applied Epidemiology Fellow Kentucky Department for Public Health Phone: (502)564-3261 x3278 Email: [email protected] 36
 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
									 
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                             
                                            